|
Cytoreductive nephrectomy (CN) in metastatic renal cancer (mRCC): Update on Carmena trial with focus on intermediate IMDC-risk population. |
|
|
Honoraria - Ipsen; Novartis; Pfizer |
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Sanofi |
Research Funding - Pfizer (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Novartis; Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - BMS , Novartis, Ipsen, Pfizer |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Pfizer ipsen |
|
|
Honoraria - Bristol-Myers Squibb; Intuitive Surgical; Ipsen |
Consulting or Advisory Role - Bristol-Myers Squibb; MSD |
Travel, Accommodations, Expenses - Ipsen; Pfizer |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; MSD Oncology |
Travel, Accommodations, Expenses - Ipsen; Janssen Oncology; MSD Oncology |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - IPSEN; Janssen-Cilag; Sanofi |
Travel, Accommodations, Expenses - Bouchara Recordati; IPSEN; Janssen-Cilag |
|
|
Honoraria - Ipsen; Takeda |
Travel, Accommodations, Expenses - Astellas Pharma; Intuitive Surgical; Janssen; Pierre Fabre |
|
|
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen; Pfizer |
Expert Testimony - MSD; Novartis; Sanofi |
|
|
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Ipsen; Janssen Oncology; Pfizer |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer |
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; Pfizer |
|
|
|
Honoraria - Astellas Pharma |
Consulting or Advisory Role - Astellas Pharma |
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Pfizer |
|
|
Honoraria - Astellas Pharma; Ipsen; Janssen-Cilag; Sanofi Pasteur |
Consulting or Advisory Role - Janssen-Cilag |
Travel, Accommodations, Expenses - Ferring; Janssen-Cilag |
|
|
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck (Inst); Novartis; Novartis (Inst); Pfizer (Inst); Roche (Inst) |
|
|
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Janssen; Merck; Novartis; Pfizer; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Janssen; Merck; Novartis; Pfizer; Sanofi |
Research Funding - Ipsen; Sanofi |
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Eisai; Merck; Novartis; Pfizer |
|
|
Honoraria - Novartis; Pfizer |
Consulting or Advisory Role - AstraZeneca; Bayer |
Speakers' Bureau - AstraZeneca |
Travel, Accommodations, Expenses - AstraZeneca |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Pfizer; Roche/Genentech |
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Pfizer; Roche/Genentech |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Pfizer; Roche/Genentech |
|
|
Honoraria - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer |
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Novartis; Pfizer; Roche |
Research Funding - Pfizer (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; ipsen; MSD; Novartis; Pfizer; Roche |